Bumper Offer - Urjas oil Just @ Rs. 1 X
Recita 10 Tablet is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Depression. Recita 10 Tablet also has some secondary and off-label uses. These are listed below.
The right dosage of Recita 10 Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Recita 10 Tablet can also lead to other problems, which have been listed below. Usually, these side effects of Recita 10 Tablet go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Recita 10 Tablet is Moderate for pregnant women and Severe for women who are breastfeeding. It is important to know if Recita 10 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Recita 10 Tablet related warnings section.
Other contraindications of Recita 10 Tablet have been discussed in the sections ahead.
Drug interactions for Recita 10 Tablet have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Recita 10 Tablet is considered not safe while driving, and is not addictive.
Recita 10 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Adult(Male) |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Recita 10 Tablet is used -
Moderate
Mild
Is the use of Recita 10 Tablet safe for pregnant women?
Recita may have some side effects during pregnancy. Pregnant women should discontinue the use of Recita, and talk to their doctor, if they notice any discomfort.
Is the use of Recita 10 Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Recita. It should only be taken after medical advice.
What is the effect of Recita 10 Tablet on the Kidneys?
Recita has very mild side effects on the kidneys.
What is the effect of Recita 10 Tablet on the Liver?
Recita is rarely harmful for the liver.
What is the effect of Recita 10 Tablet on the Heart?
Recita is rarely harmful for the heart.
Recita 10 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Recita 10 Tablet unless your doctor advises you to do so -
Is this Recita 10 Tablet habit forming or addictive?
Recita 10 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Recita 10 Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Recita 10 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Yes, this Recita 10 Tablet works for mental disorders.
Interaction between Food and Recita 10 Tablet
Taking Recita 10 Tablet with food does not harm your health.
Interaction between Alcohol and Recita 10 Tablet
Taking Recita 10 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522